A shadow market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on messaging platforms, according to recent findings.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where communities with numerous of members share comparison images, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Experts Voice Worries
However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could result in users administering products of uncertain source.
Some experts stated the popularity for the experimental drug could be connected to the rising price of licensed weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.
Some influencers try to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.
Platform Reaction and Content Removal
Based on the social media company, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Online Trading Activities
Research also discovered communities with up to 9,000 members selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly displays groups with thousands of members, filled with photos of slimming results, positive reviews and step-by-step guides for mixing or injecting at residence.
Within moments of entering one community, a seller posted contact information, where most purchases occur. The seller provided an guidebook and promised delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or previous experience.
Item Details and Pricing
Within these groups, messages show black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how much time a pen should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A representative for Telegram said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online versions may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, individuals are using online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.
Her staff has already encountered individuals harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose users to potentially significant health risks”.
